SF AIDS Fdn: BETA 3/97 -- Table of Contents

Bulletin of Experimental Treatments for AIDS (BETA), published by the San Francisco AIDS Foundation, is one of the most comprehensive HIV treatment publications, with hundreds of in-depth articles.

BETA is published quarterly by the San Francisco AIDS Foundation.

Main page

Subscribe (free)

beta@sfaf.org

March 1997 Table of Contents

Features

3-Drug Therapy Reduces Deaths and New AIDS-Related Illnesses by 50%

Declines in AIDS-Related Deaths and Hospitalizations

Glaxo Wellcome Responds to AIDS Community Concerns about Early Access to 1592

Hydroxyurea

Psychiatric Aspects of HIV

Peripheral Neuropathy

Chemokines and HIV

A History of Chemokines

Types and Names of Antiretroviral Drugs (table)

Departments

BETA News Briefs

Women and HIV
-- Recent News about Women and HIV
-- NIH Reaffirms Support for Perinatal AZT Despite Cancer Findings

Conference Coverage

-- Selected Highlights from the 4th Conference on Retroviruses and Opportunistic Infections

Glossary

Notice

The statements and opinions in BETA are published as an educational resource only, and do not imply recommendation or endorsement by BETA or the San Francisco AIDS Foundation. Always consult a physician before taking any drug or changing a drug regimen.

Contributors to this issue:

Ronald Baker, PhD
Harvey S. Bartnof, MD
Mark Bowers
Leslie Hanna
Liz Highleyman
Mary Romeyn

Page last updated 1 April 1997